Lab Outpabent Blood Collecbon entered the industry of Commercial Research Laboratory in 2007 and has grown to employ 1 to 4 people, generating an annual revenue of $0 to $49.999. The NAICS classifies this business under the code 541712, which describes it as a Commercial Research Laboratory. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Research Laboratory. The business provides service to the B2B market.
To acquire more information, please contact Paul Newbold by calling (850) 942-2733 during business hours. You can also write to the business’ Single Location at 2433 Mahan Drive, Tallahassee, Florida FL 32308. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
Company: | Lab Outpabent Blood Collecbon |
Representative: | Paul Newbold |
Place of Business: | 2433 Mahan Drive, Tallahassee, FL 32308 |
Contact Number: | (850) 942-2733 |
Type of Service: | Commercial Research Laboratory |
SIC Number: | 8731 |
NAICS Number: | 541712 |
Locality: | Single Location |
Market Type: | B2B (Business to Business) |
Began: | 2007 |
Income/Year: | $0 to $49.999 |
Laborers: | 1 to 4 |
Share This Company: |
Lab Outpabent Blood Collecbon is a company operating from Leon, Florida providing professional Commercial Research Laboratory and relevant B2B variables. It was founded in 2007 and registered with the SIC code 8731 as Commercial Research Laboratory, and with the NAICS code 541712 as Commercial Research Laboratory.
With a current employee count of 1 to 4, Lab Outpabent Blood Collecbon has gone to report making $0 to $49.999 per annum on its journey towards growth. This company invites you to contact its representative Paul Newbold at (850) 942-2733 for related queries, or to locate its Single Location using the coordinates .
The Single Location can also be found at the street address 2433 Mahan Drive in Tallahassee, Florida 32308 and can be engaged online through the company website at , the company Twitter , and Facebook page .